News for 'Drugs Prices Control Order'

160 terrorists waiting in launchpads across LoC, says Army commander

160 terrorists waiting in launchpads across LoC, says Army commander

Rediff.com22 Nov 2022

Around 300 terrorists are present in Jammu and Kashmir, while 160 others are waiting on the launchpads for an opportunity to sneak into this side from across the Line of Control (LoC) in Pakistan, a top army commander said on Tuesday.

Dr Reddy's A-team moves on putting house in order

Dr Reddy's A-team moves on putting house in order

Rediff.com10 Oct 2018

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.

Masks, hand sanitiser declared 'essential commodities'

Masks, hand sanitiser declared 'essential commodities'

Rediff.com14 Mar 2020

These items will remain under essential commodities segment till June-end, a move aimed at ensuring availability at reasonable prices and cracking down on hoarders/black marketeers.

Congress leader moves SC for probing Hindenburg's Adani group claims

Congress leader moves SC for probing Hindenburg's Adani group claims

Rediff.com14 Feb 2023

A plea has been filed in the Supreme Court seeking investigation under the supervision of a sitting apex court judge against the Adani group of companies in light of the allegations made by the US-based Hindenburg Research.

Nawab Malik exposed farce behind Aryan case: Raut

Nawab Malik exposed farce behind Aryan case: Raut

Rediff.com28 May 2022

Talking to reporters in Kolhapur, Raut said Malik is paying the price for exposing the farce behind the case and the real face of the BJP.

SC to hear Congress leader's PIL for Adani probe on Friday

SC to hear Congress leader's PIL for Adani probe on Friday

Rediff.com15 Feb 2023

The Supreme Court on Wednesday agreed to hear on February 17 a fresh plea of a Congress leader seeking investigation under the supervision of a sitting apex court judge against the Adani group of companies in light of the allegations made by the US-based Hindenburg Research.

'We will price Covid vaccine below Rs 1,000'

'We will price Covid vaccine below Rs 1,000'

Rediff.com29 Jul 2020

Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.

COVID-19: Pak SC asks govt to sack top health advisor

COVID-19: Pak SC asks govt to sack top health advisor

Rediff.com13 Apr 2020

During a hearing on a suo motu case on the coronavirus crisis in Pakistan, a five-member bench of the apex court observed that PM Khan's Cabinet has become ineffective in the fight against the pandemic. The bench questioned the integrity of Dr Mirza in tackling the COVID-19 crisis and the transparency of his work done.

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Rediff.com23 Jun 2020

While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.

Gujarat firm gets licence to make covid-19 test kits

Gujarat firm gets licence to make covid-19 test kits

Rediff.com22 Mar 2020

A joint venture of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises (ASE), and CoDiagnostics, CoSara Diagnostics is the first and only Indian company so far to receive a licence from the Central Drugs Standard Control Organisation (CDSCO) to manufacture coronavirus diagnostic test kits.

Winter session begins today, farm law repeal among 26 bills on agenda

Winter session begins today, farm law repeal among 26 bills on agenda

Rediff.com29 Nov 2021

The government's agenda also includes the Cryptocurrency and Regulation of Official Digital Currency Bill, 2021.

Producing vaccines is not like making 2 minutes noodles

Producing vaccines is not like making 2 minutes noodles

Rediff.com27 May 2021

'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.

Govt approves plan to turn surplus rice into sanitizer

Govt approves plan to turn surplus rice into sanitizer

Rediff.com21 Apr 2020

The government allowed sugar companies and distilleries to make hand sanitizers using ethanol. Sugar companies supply ethanol to oil marketing companies for blending with petrol.

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Rediff.com14 Apr 2020

As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.

Politicians have no business to hoard stocks of COVID-19 medicines: HC

Politicians have no business to hoard stocks of COVID-19 medicines: HC

Rediff.com17 May 2021

"Just because some political figures are involved, you will not investigate, we will not allow this," said the court adding that it would have appreciated if the police had enquired into specific allegations levelled against each person and then filed the report.

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Overcharging: Cipla fined Rs 748 cr

Overcharging: Cipla fined Rs 748 cr

Rediff.com13 Apr 2007

The National Pharmaceutical Pricing Authority has asked Cipla, the second biggest domestic drug maker, to pay Rs 748.27 crore (Rs 7.48 billion) as fine towards overcharging of controlled drugs.

Winter session of Parliament to begin on stormy note on Monday

Winter session of Parliament to begin on stormy note on Monday

Rediff.com28 Nov 2021

The opposition will seek to target the government on the issue of farmers' plight as well as their demand for a legal backing for minimum support price.

India may get first Covid-19 vaccine by February

India may get first Covid-19 vaccine by February

Rediff.com30 Nov 2020

The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.

Coronavirus: Products that will be hit the most in India

Coronavirus: Products that will be hit the most in India

Rediff.com20 Feb 2020

If not contained quickly, it will have a knock-on effect in the world economy and disrupt global supply chains, Crisil analysts warned.

High & mighty of India Inc faced the music in 2014

High & mighty of India Inc faced the music in 2014

Rediff.com2 Jan 2015

The year gone by saw the high and mighty of the corporate world face the music in the Delhi High Court which held that the telecom majors are amenable to CAG audit and Mukesh Ambani's RIL struggling hard to get rid of an FIR lodged on gas pricing by the 49-day-old AAP regime.

Vaccine drive set in motion, 13 cities get first consignment

Vaccine drive set in motion, 13 cities get first consignment

Rediff.com12 Jan 2021

A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.

Govt likely to fast-track import restrictions on 371 Chinese goods

Govt likely to fast-track import restrictions on 371 Chinese goods

Rediff.com30 Jun 2020

The government has been gearing up to place tighter restrictions on the import of 371 items - ranging from toys and plastic goods to sports items, and furniture worth $127 billion.

North India could see 100,000 cases per state per day

North India could see 100,000 cases per state per day

Rediff.com19 Apr 2021

'The trajectory of the disease will keep increasing because of the population density being very high.'

Pandemic moving eastwards, says Govt; reviews situation with 5 states

Pandemic moving eastwards, says Govt; reviews situation with 5 states

Rediff.com5 May 2021

A rise in the number of daily COVID-19 cases and mortality has been observed in Assam, West Bengal, Odisha, Bihar and Jharkhand, indicating the pandemic is moving eastwards, the Union health ministry said.

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'

Markets end flat after Fed-led rally loses steam

Markets end flat after Fed-led rally loses steam

Rediff.com17 Mar 2016

Pharma shares extended losses after the government's ban on combination drugs.

Markets end on a cautious note ahead of Nov F&O expiry; Winter session eyed

Markets end on a cautious note ahead of Nov F&O expiry; Winter session eyed

Rediff.com24 Nov 2015

Top gainers from the Sensex pack are ONGC, HDFC, HUL, RIL and Cipla.

In Mexico, Trump insists on building 'border wall'

In Mexico, Trump insists on building 'border wall'

Rediff.com1 Sep 2016

However, he refrained from speaking on Mexican immigrants and also declined to repeat his frequent promise to force Mexico to pay for the wall.

Markets kick off Q3 on a positive note; Sensex, Nifty end higher

Markets kick off Q3 on a positive note; Sensex, Nifty end higher

Rediff.com1 Oct 2015

Markets in green tracking firm global cues.

2018: Year of reckoning for India Inc

2018: Year of reckoning for India Inc

Rediff.com28 Dec 2018

A glance back at some of the important ups and down Indian Inc faced in 2018.

The man who wants to buy Dawood's property

The man who wants to buy Dawood's property

Rediff.com4 Dec 2015

'I would like to say that there is a fear of Dawood. We thought we are a nation of 120 crore people and if we do not bid for this property it will be a matter of disgrace.' 'Here is this man sitting in Pakistan and is being able to lord over our country especially Mumbai through remote control. I think somewhere we must draw the line.' 'There is no Hindu-Muslim issue at all. The underworld is the most secular entity in the country. Whether you are a Muslim or a Hindu it does not matter. Whether you are able to deliver or rake in the moolah is all that matters.' Former journalist S Balakrishnan on why he is bidding for Dawood's Ibrahim's property.

Will Punjab slip back into militancy?

Will Punjab slip back into militancy?

Rediff.com2 Nov 2015

It is as much about farmer woes and the lack of job opportunities as about the mixing of religion and politics.

Jat agitation does not mean well for India

Jat agitation does not mean well for India

Rediff.com26 Feb 2016

Unprecedented violence... Mobs determined to teach Delhi a lesson... An incompetent chief minister... Losses of over Rs 200 billion. Haryana's Jat agitation has a somber message for the nation.

Demonetisation: Opposition deposits ire in Rajya Sabha

Demonetisation: Opposition deposits ire in Rajya Sabha

Rediff.com16 Nov 2016

Launching a scathing attack on Prime Minister Narendra Modi, Opposition parties on Wednesday alleged that selective leak of information on demonetisation of 500 and 1000 rupee notes to 'friends of BJP' and demanded making public the names of those who had bought gold and foreign exchange of over Rs 1 crore since April.

« Prev  |